Forte Biosciences, Inc. 37TA.F Stock
0.53 EUR
{{ price }}
0.952380%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
19.73M EUR
LOW - HIGH [24H]
0.53
-
0.53 EUR
VOLUME [24H]
15 EUR
{{ volume }}
P/E Ratio
0
Earnings per share
-0.77 EUR
Forte Biosciences, Inc. Price Chart
Forte Biosciences, Inc. 37TA.F Financial and Trading Overview
| Forte Biosciences, Inc. stock price | 0.53 EUR |
| Previous Close | 0.93 EUR |
| Open | 0.93 EUR |
| Bid | 0.91 EUR x N/A |
| Ask | 0.94 EUR x N/A |
| Day's Range | 0.93 - 0.93 EUR |
| 52 Week Range | 0.89 - 1.5 EUR |
| Volume | 100 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 20.22M EUR |
| Beta (5Y Monthly) | 1.391972 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.77 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.25 EUR |
37TA.F Valuation Measures
| Enterprise Value | -16324389 EUR |
| Trailing P/E | N/A |
| Forward P/E | -1.2333333 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.5899235 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Forte Biosciences, Inc. Stock Price History
| Beta (5Y Monthly) | 1.391972 |
| 52-Week Change | -17.90% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.5 EUR |
| 52 Week Low | 0.89 EUR |
| 50-Day Moving Average | 0.94 EUR |
| 200-Day Moving Average | 0.99 EUR |
37TA.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 21.05M |
| Float | 12.91M |
| Short Ratio | N/A |
| % Held by Insiders | 18.56% |
| % Held by Institutions | 37.75% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -29.22% |
| Return on Equity (ttm) | -49.49% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -18065000 EUR |
| Diluted EPS (ttm) | -0.86 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 35.9M EUR |
| Total Cash Per Share (mrq) | 1.71 EUR |
| Total Debt (mrq) | 0 EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 9.647 |
| Book Value Per Share (mrq) | 1.568 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -11414000 EUR |
| Levered Free Cash Flow (ttm) | -5050125 EUR |
Profile of Forte Biosciences, Inc.
| Country | Germany |
| State | TX |
| City | Dallas |
| Address | 3060 Pegasus Park Drive |
| ZIP | 75247 |
| Phone | 310 618 6994 |
| Website | https://www.fortebiorx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 7 |
Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
Q&A For Forte Biosciences, Inc. Stock
What is a current 37TA.F stock price?
Forte Biosciences, Inc. 37TA.F stock price today per share is 0.53 EUR.
How to purchase Forte Biosciences, Inc. stock?
You can buy 37TA.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Forte Biosciences, Inc.?
The stock symbol or ticker of Forte Biosciences, Inc. is 37TA.F.
Which industry does the Forte Biosciences, Inc. company belong to?
The Forte Biosciences, Inc. industry is Biotechnology.
How many shares does Forte Biosciences, Inc. have in circulation?
The max supply of Forte Biosciences, Inc. shares is 37.22M.
What is Forte Biosciences, Inc. Price to Earnings Ratio (PE Ratio)?
Forte Biosciences, Inc. PE Ratio is now.
What was Forte Biosciences, Inc. earnings per share over the trailing 12 months (TTM)?
Forte Biosciences, Inc. EPS is -0.77 EUR over the trailing 12 months.
Which sector does the Forte Biosciences, Inc. company belong to?
The Forte Biosciences, Inc. sector is Healthcare.